nDash.com is a content creation platform that provides brands and agencies with access to the world's top freelance writers.

nDash Writer Profile for Julia Omotade

Headline

unparelled scientific writing is only one click away

About Me

My name is Julia Omotade and I have a passion for writing at the intersection of science.

I am senior science policy specialist at one of the world's leading academic medicine and policy associations. I work on a specialized scientific affairs team covering the nation's most pressing scientific and biomedical policy issues. 

By training, I am a cellular and molecular neuroscientist. This title sounds a lot fancier than it is.  What it really means is that I have an advanced degree (PhD) in Biology - the study of dynamics, systems, molecules, and mechanisms that contribute to life. 

The study of biology is broad, and so is my expertise. When you learn science as I have - by looking at it through the microscopes, by examining DNA, by carefully handling poisons, speaking with Nobel laureates, and by teaching it to fifth graders and undergraduates alike - you begin to learn certain truths of science. Every scientist will have established their own guiding truths which motivates, drives, or inspires them. Here are mine, which, are intimately tethered to my writing.


Julia Omotade's Guiding Beliefs

1. Scientific disciplines, though important for facilitating the study of what would be an otherwise complex natural world, are inherently articifial. What I mean is that scientific disciplines do not exist in silos; but rather, are interconnected. For example, genetics is neuroscience and neuroscience is biochemistry. To the cell, to the body - there is no difference between physics, chemistry or biology. In between life and death are all scientific disciplines - working together, cohesively - not divided among textbooks. As a cell biologist, microscopist and neuroscientist, my lens is a unique one and at times, may veer towards one discipline or field. It's important to remember, though, that science knows no boundaries.

2. Science is not only the 'what'; but the 'who'. When we think about clinical trials, medicine, experiments, scientific boards, merits, and awards - when we think about academic medicine - our deans, leaders, nurses, teachers - we must remember that these individuals are science. Not what they do, but who they are. The people, the workforce, the community - this is what makes science so fundamentally great. An understanding of this - of the human capital side of science - and everything that comes with it - the ethics, the struggles, the conflicts, is what makes a scientific story comprehensive and wholesome. 

3. Lastly, science is marbled with a long history of inequities and disparities - particularly against women and racial and ethnic minorities. As a policy specialist at one of the U.S.' leading associations, I welcome others to think about our scientific enterprise as a fight for equality. We must reckon with the history of marginalization, exclusion, and under-representation if we are to make real gains in changing the face of science and making it accessible for all.

Industries I Write About

Health & Wellness

Find writers and ideas in this industry

Science & Medicine

Find writers and ideas in this industry

My Writing Samples

AAMC Coronavirus Update Letter

To help filter through the large volume of news about the coronavirus, Ross McKinney Jr., MD, AAMC chief scientific officer, together with Julia Omotade, PhD, write this science-focused newsletter that covers evidence-based COVID-19 research, clinical, treatment, and policy updates utilized by the U.S. academic medicine community.

https://image.email.aamc.org/lib/fe8e13727c63047f73/m/2/c53ab2fd-3a5c-482d-9cbc-059a30aa9373.pdf

50 Years of Women in Cell Biology: Where have we been? Where are we going?

To commemorate the 50th anniversary of the American Society for Cell Biology Women in Cell Biology (WICB) group, my co-authors and I thoughtfully and strategically highlight the challenges that women in science have faced in the past, and today. We anticipate and discuss new challenges that will arise in the next 50 years and state the role that scientific societies can play in fostering gender equity and parity in the biomedical community.

https://www.molbiolcell.org/doi/full/10.1091/mbc.E21-04-0186

AAMC Comments on National Artificial Intelligence Initiative

On behalf of the Association of American Medical Colleges, I wrote and submitted a letter to the White House Office of Science and Tech. Policy (OSTP) and the National Science Foundation (NSF) on Sept. 1 in response to a request for information (RFI) geared toward developing a shared, national artificial intelligence (AI) research infrastructure, the National Artificial Intelligence Research Resource (NAIRR).

https://www.aamc.org/media/56226/download?attachment

Tropomodulin Isoform-Specific Regulation of Dendrite Development and Synapse Formation

This publication condenses complex content and novel experimental findings from my doctoral work. The intended audience is the academic medicine community.

https://www.jneurosci.org/content/38/48/10271/tab-figures-data

Regulation of Dendrite Development and Synapse Formation by Tropomodulin

Thesis dissertation written as a culmination of 5.5 years of laboratory research. The introduction segment is written for a scientific and lay audience alike.

https://etd.library.emory.edu/concern/etds/9c67wm82b

Experience

AAMC COVID-19 Newsletter Co-Lead and Writer

Together with the Chief Scientific Officer at the AAMC, Ross McKinney, Jr., M.D., I co-lead the AAMC Coronavirus Newsletter - a trusted science-focused newsletter covering evidence-based COVID-19 research, clinical, treatment, and policy updates utilized by the U.S. academic medicine community. The newsletter started Ad Hoc at the genesis of the COVID-19 pandemic, and has since become a vanguard for fact-based, digestible updates that filters through the large volume of news about the coronavi

Company: Association of American Medical Colleges

I worked there from 4/2021 until now

Senior Science Policy Specialist

I am a Senior Science Policy Specialist at the Association of American Medical Colleges, where she tackles our nation's biomedical policy issues. Her portfolio includes artificial intelligence, scientific training and workforce; diversity, equity and inclusion of the US biomedical workforce; sexual harassment in science and; gender equity and parity in science; new, national and regional research initiatives; the National Institutes of Health, and coronavirus research and COVID-19.

Company: Association of American Medical Colleges

I worked there from 3/2021 until now

Senior Healthcare Executive Search Consultant

After a 10-year career in research, Julia transitioned to healthcare consulting and recruiting, where she worked with organizations such as TheNational Academies of Science, Engineering and Medicine; The Association for Women in Science; and the Broad Institute - placing leaders at the right time to drive discovery, health, and care

Company: Isaacson, Miller

I worked there from 12/2017 until 2/2021

Journal Reviewer

I volunteer and assess manuscripts for the journal Academic Medicine.

Company: Journal: Academic Medicine

I worked there from 2/2022 until now

Content I Write